GianlucaIaniro,MD

BorninCampobasso,Italy,onthe1stofJanuary,1985Nationality:ItalianForeignLanguages:EnglishOfficeaddress:LargoA.Gemelli,8–Rome,Italypostcode00168Email:gianluca.ianiro@hotmail.it.Skypeaddress:gianluca.ianiroTwitter:@gianluca1aniro

EducationandprofessionalexperienceMEDICALTRAINING2003:HighSchoolGraduation,withhighesthonours2009:Medicaldegreesummacumlaude,CatholicUniversityofRome2010:ItalianMedicalBoardCertification,withhighesthonours2011toJune2016TraininginGastroenterologyatCatholicUniversityofRome,Italy(Chief:Prof.AntonioGasbarrini)–summacumlaudeCURRENTWORKINGPOSITIONConsultantattheGastroenterologyUnitoftheFondazionePoliclinicoUniversitario“A.Gemelli”IRCCS,Rome,Italy(fromJuly2016)RelevantacademicandresearchactivitiesLicenseasAssociateProfessorinGastroenterology(MED/12)sinceOctober2018SCIENTIFICSOCIETIES:Currentmember:

- UEG(UnitedEuropeanGastroenterology)-ResearchCommittee(currentmember),YoungTalentGroup(formermember)

- SIGE(ItalianSocietyofGastroenterology)–MemberoftheGoverningBoard.FriendofYoungTalentGroupforSIGE

EDUCATIONALANDTEACHINGACTIVITIES- FounderandformerChairoftheItalianCouncilofTraineesinGastroenterology.During

hischairmanship,theItalianCouncilofTraineesinGastroenterologywentundertheumbrellaoftheItalianSocietyofGastroenterology,andtookpartinthedevelopmentofanationalactivitylogbookforgastroenterologytraining

- LeadAuthoroftheUEGe-learningcourse“FaecalMicrobiotaTransplantation”- Course Director of the UEG Basic Science Course 2017 “Gut microbiota: relevance,

analysis,modulation”- Appointed by the UEG Scientific Committee to represent UEG at ECCMID 2017, in a

“Meet-The-Expert” session (co-organized by UEG and ESCMID) on fecal microbiotatransplantation.

- Member of the Scientific Committee and Teaching Faculty of the EAGEN/EHMSGPracticeCourseon“FecalMicrobiotaTransplantation

- ParticipantintheMaastrichtV/FlorenceConsensusConferenceforthemanagementofH.pyloriinfection

- TeachingactivityofpracticelessonswithintheGastroenterologyCourseoftheCatholicUniversityofSacredHeartofRomeSchoolofMedicine,Italy

- TeachingactivitywithintheEnglishGastroenterologyCourse“Medicine&Surgery”oroftheCatholicUniversityofSacredHeartofRomeSchoolofMedicine,Italy

- Teaching appointment of “Pathophysiology of celiac disease” within the 2°level-Master’s program in “Molecular diagnosis in personalized medicine” of the CatholicUniversityofSacredHeartofRomeSchoolofMedicine,Italy

HONOURS,AWARDSANDGRANTS

GRANTS-ItalianHealthMinistry,project“Targetinggutmicrobiotatoimproveefficacyofimmunecheckpointinhibitorsinpatientswithadvancedrenalcellcarcinoma”(Year:2018–Role:PrincipalInvestigator-Grantamount:450000€)-ItalianHealthMinistry,project“Establishingafecalmicrobiotatransplantserviceforthetreatment of Clostridium difficile infection (Year: 2017 – Role: Collaborator - Grantamount:283000€)- Catholic University of Rome, project “Ruolo del Bacillus clausii nella modulazione delmicrobiota intestinaledopo terapiaantibiotica” (Year:2017–Role:Collaborator–Grantamount:8000€)-UEG,educationalproject“Fecalmicrobiotatransplantationdisseminationproject”(Year:2016–Role:Co-coordinator–Grantamount:100000€)- Catholic University of Rome, project “Alterazione della composizione del microbiotaintestinale in pazienti giovani sottoposti a terapia antibiotica eradicante per H. pylori”(Year:2017–Role:Collaborator–Grantamount:8000€)- UEG, educational project “Practice Course on Fecal microbiota transplantation” (Year:2015–Role:Co-coordinator–Grantamount:25000€)- Catholic University of Rome, project “Valutazione metagenomica di gut microbiotanell'esofagodiBarrett”(Year:2017–Role:Collaborator–Grantamount:8000€)-CatholicUniversityofRome,project“Iltrapiantofecaleneltrattamentodellaricorrenzadi infezione da Clostridium difficile” (Year: 2017 – Role: Collaborator – Grant amount:8000€)- Catholic University of Rome, project “Ruolo del campionamento bioptico endoscopiconella determinazione dello stato di her2 nell'adenocarcinoma gastrico: studio diaccuratezzadiagnostica”(Year:2017–Role:Collaborator–Grantamount:8000€)AWARDS-Bestpaperaward-FISMAD2017(5000€)-TravelgrantsfortheUEGWeek2015,2016,2017(1000€each)-Bestposteraward-FISMAD2016(1000€)

CONGRESSANDCOURSEACTIVITIES- Attendance tomany national and international gastroenterology conferences (including

UEGWeek,ECCMID,severalEAGENandEHMSGcourses)as invitedspeaker/chairmanin

thefieldofgutmicrobiota- Selectedtoparticipateinseveralnationalandinternationalresearchcoursesdedicatedto

young trainees (such asUEGSummer School andUEGYoung InvestigatorMeeting, bothendorsedbyUnitedEuropeanGastroenterology,andGastroAPDW/WCOG)

EDITORIALACTIVITY- AssociateEditoroftheHumanMicrobiomeJournal(Elsevier)- Editorial BoardMembership of the journal Reviews In Gastroenterology Hepatology

AndNutrition.- Ad-hocJournalScanContributorforGut.- ReviewerforthefollowingJournals:

The Lancet; The Lancet Infectious Diseases; Annals of InternalMedicine; Gut;Circulation;CirculationResearch;TheLancetGastroenterologyandHepatology;Clinical Gastroenterology and Hepatology; Alimentary Pharmacology &Therapeutics;GastrointestinalEndoscopy;EBioMedicine;ClinicalMicrobiologyand Infection; Scientific Reports; EbioMedicine; Plos One; Journal ofAntimicrobialChemotherapy;ScandinavianJournalofGastroenterology;BritishJournal of Clinical Pharmacology; Journal of Clinical Gastroenterology; ExpertOpinion on Biological Therapy; Expert Review of Gastroenterology andHepatology; Current Medicinal Chemistry; Current Drug Targets; Nutrients;DigestiveandLiverDisease;FutureMicrobiology; JournalofFunctionalFoods;WorldJournalofGastroenterology;JournalofInfectionandPublicHealth;WorldJournalofGastrointestinalEndoscopy;EndoscopyInternationalOpen;AnnalsofGastroenterology; Future Virology; Annals of Hepatology; Expert Review ofVaccines; Experimental Dermatology; Expert Opinion on Biological Therapy;Expert Opinion on Pharmacotherapy; Neuroscience; Expert Review ofRespiratory Medicine; European Review for Medical and PharmacologicalSciences; Gynecological Endocrinology; Current Medical Research & Opinion;Current Alzheimer Research; Gastroenterology Research and Practice. ScienceChinaLife Sciences;BMJCaseReports;World Journal ofBiological Psychiatry;MinervaGastroenterologicaDietologica; Innate Immunity; SAGEOpenMedicalCaseReports.

RESEARCHSKILLS

- Skilledinorganizingresearchworkinggroups:o Secretary of the first European Consensus Conference on fecal microbiota

transplantationinclinicalpractice(publishedinGutonJanuary2017)o AppointedbythecurrentChairoftheYoungTalentGroup(J.Burisch)toleadthe

preparationofapaperdescribingtherecentsurveyofFriendsofYoungTalentGroupreleasedbytheYoungTalentGroupin2017

o Coordinator of a European working group of delegates of several younggastroenterology sections across Europe, which developed an internationalsurveyongastroenterologytraininginEurope,presentedatUEGWeek2016

- Skilledindesigningresearchprotocolsandinattendingscientifictrials- Experienced as sub-investigator in many phase II and III clinical trials in

gastroenterologyarea- Goodknowledgeofmedicalstatisticsandepidemiology- ExperiencedintheuseofExcel,EndNote,andofmanystatisticalcomputerprograms

PublicationsImpactFactor:534H-Index:28(GoogleScholar);24(Scopus)INEXTENSOPUBLICATIONS(IndexedforMEDLINE)1. CammarotaG,CazzatoA,GenoveseO,PantanellaA,IaniroG,GiorgioV,MontaltoM,VecchioFM,

Larocca LM, Gasbarrini G, Fundarò C. Water immersion technique during standard upperendoscopymaybeusefultodrivethebiopsysamplingofduodenalmucosainchildrenwithceliacdisease.JPediatrGastroenterolNutr.2009Oct;49(4):411-6.

2. MontaltoM,GalloA,IaniroG,SantoroL,D'onofrioF,RicciR,CammarotaG,CovinoM,VastolaM,Gasbarrini A, Gasbarrini G. Can chronic gastritis cause increase of fecal calprotectinconcentrations?.WorldJGastroenterol.2010Jul21;16(27):3406-10

3. CammarotaG.,BrancaG,ArditoF,SanguinettiM,IaniroG,CianciR,TorelliR,MasalaG,GasbarriniA, Fadda G, Landolfi R, Gasbarrini G. Biofilm demolition and antibiotic treatment to eradicateresistantHelicobacterpylori:aclinicaltrial.ClinGastroenterolHepatol.2010Sep;8(9):817-820.e3

4. VitaleG,BarbaroF,IaniroG,CesarioV,GasbarriniG,FranceschiF,GasbarriniA.NutritionalaspectsofHelicobacterpyloriinfection.MinervaGastroenterolDietol.2011Dec;57(4):369-77

5. Gigante G, Tortora A, Ianiro G, Ojetti V, Purchiaroni F, Campanale M, Cesario V, Scarpellini E,GasbarriniA.Roleofgutmicrobiotainfoodtoleranceandallergies.DigDis.2011;29(6):540-9.doi:10.1159/000332977

6. Rinninella E, ZoccoMA,DeGaetanoA, Iezzi R, CampanaleM, CesarioV, Barbaro F, Ponziani FR,Caracciolo G, Triarico S, Tortora A, Ianiro G, Gasbarrini A. From small nodule to overt HCC: amultistepprocessofcarcinogenesisasseenduringsurveillance.EurRevMedPharmacolSci.2012Sep;16(9):1292-4.

7. CammarotaG,IaniroG,SparanoL,LaMuraR,RicciR,LaroccaLM,LandolfiR,GasbarriniA.Image-EnhancedEndoscopywithI-scanTechnologyfortheEvaluationofDuodenalVillousPatterns.DigDisSci.2013May;58(5):1287-92.

8. Ianiro G, Cammarota G, Valerio L, Annicchiarico BE, Milani A, Siciliano M, Gasbarrini A.Microscopiccolitis.WorldJGastroenterol.2012Nov21;18(43):6206-15

9. CianciR,CammarotaG,FrisulloG,PagliariD,IaniroG,MartiniM,FrosaliS,PlantoneD,DamatoV,CascianoF,LandolfiR,PaolaBatocchiA,PandolfiF.Tissue-infiltratinglymphocytesanalysisrevealslargemodificationsoftheduodenal"immunologicalniche"incoeliacdiseaseaftergluten-freediet.ClinTranslGastroenterol.2012Dec13;3:e28

10. Purchiaroni F, Tortora A, Gabrielli M, Bertucci F, Gigante G, Ianiro G, Ojetti V, Scarpellini E,GasbarriniA.The roleof intestinalmicrobiotaand the immunesystem.EurRevMedPharmacolSci.2013Feb;17(3):323-33.

11. BiolatoM,AlfieriS,IaniroG,PizzoferratoM,GasbarriniG.Gastricnon-secretingneuroendocrinetumor and hypochlorhydria-related hypergastrinemia: a case report. J Med Case Rep. 2013 Feb22;7(1):53.

12. D'AversaF,TortoraA, IaniroG, PonzianiFR,AnnicchiaricoBE,GasbarriniA.Gutmicrobiotaandmetabolicsyndrome.InternEmergMed.2013Apr;8Suppl1:11-5.

13. Scaldaferri F, Petito V, Lopetuso L, Bruno G, Gerardi V, Ianiro G, Sgambato A, Gasbarrini A,CammarotaG.Pre-andPosttherapyAssessmentofIntestinalSolubleMediatorsinIBD:WhereWeStandandFuturePerspectives.MediatorsofInflammation–2013;2013:391473.

14. IaniroG,PizzoferratoM,FranceschiF,TarulloA,LuisiT,GasbarriniG.Effectofanextra-virginoliveoilenrichedwithprobioticsorantioxidantsonfunctionaldyspepsia.EurRevMedPharmacolSci.2013Aug;17(15):2085-90.

15. IaniroG,BrunoG,LopetusoL,BeghellaBartoliF,LaterzaL,D'AversaF,GiganteG,CammarotaG,GasbarriniA.RoleOfYeastsInHealthyAndImpairedGutMicrobiota:TheGutMycome.CurrPharmDes.2014;20(28):4565-9.

16. IaniroG,CammarotaG,MilaniA,MettimanoM,GasbarriniA.ModeratelySevereAcutePancreatitisAssociatedWithRiluzole.JClinGastroenterol.2013Dec18.[Epubaheadofprint]

17. Laterza L, Scaldaferri F, Bruno G, Agnes A, Boškoski I, Ianiro G, Gerardi V, Ojetti V, Alfieri S,Gasbarrini A. Pancreatic function assessment. Eur Rev Med Pharmacol Sci. 2013 Dec;17 Suppl2:65-71.

18. Bruno G, Lopetuso LR, Ianiro G, Laterza L, Gerardi V, Petito V, Poscia A, Gasbarrini A, Ojetti V,ScaldaferriF.13C-octanoicacidbreathtesttostudygastricemptyingtime.EurRevMedPharmacolSci.2013Dec;17Suppl2:59-64.

19. IaniroG,GasbarriniA,CammarotaG.Endoscopic tools for thediagnosis andevaluationof celiacdisease.WorldJGastroenterol–WorldJGastroenterol.2013Dec14;19(46):8562-70.

20. DaVillaG,IaniroG,MangiolaF,DelTomaE,VitaleA,GasbarriniA,GasbarriniG.Whitemulberrysupplementation as adjuvant treatment of obesity. J Biol Regul Homeost Agents. 2014 Jan-Mar;28(1):141-5.

21. Cammarota G, Ianiro G, Gasbarrini A. Fecal Microbiota Transplantation for the Treatment ofClostridiumdifficileInfection:ASystematicReview.JClinGastroenterol.2014Sep;48(8):693-702

22. IaniroG,MangiolaF,DiRienzoTA,BibbòS,FranceschiF,GrecoAV,GasbarriniA.Levothyroxineabsorptioninhealthanddisease,andnewtherapeuticperspectives.EurRevMedPharmacolSci.2014Feb;18(4):451-6.

23. IaniroG,CammarotaG,GasbarriniA,GasbarriniG.RoleofN-acetyl-cisteineinthetreatmentofH.pylori.MinervaGastroenterolDietol.2014Mar;60(1):101.

24. CammarotaG,IaniroG,BibbòS,GasbarriniA.Gutmicrobiotamodulation:probiotics,antibioticsorfecalmicrobiotatransplantation?InternEmergMed.2014Mar25.2014Jun;9(4):365-73

25. GasbarriniGB,MangiolaF,GerardiV,IaniroG,CorazzaGR,GasbarriniA.Coeliacdisease:anoldoranewdisease?Historyofapathology.InternEmergMed.2014Apr;9(3):249-56.

26. Cammarota G, Ianiro G, Gasbarrini A, Masucci L, Sanguinetti M. Faecal transplantation forClostridiumdifficileinfection.ThreecasestreatedinItaly.DigLiverDis.2014May;46(5):475.

27. IaniroG,BibbòS,MontaltoM,RicciR,GasbarriniA,CammarotaG.Systematicreview:sprue-likeenteropathyassociatedwitholmesartan.AlimentPharmacolTher.2014May7.

28. CammarotaG, IaniroG, Bibbò S,Di RienzoTA,Masucci L, SanguinettiM, Gasbarrini A. Culture-guided treatment approach for Helicobacter pylori infection: Review of the literature. World JGastroenterol20(18):5205-5211.Publishedonline2014May14.

29. IaniroG,GasbarriniA,CammarotaG.Letter:faecalmicrobiotatransplantation:notaone-sizefitsallapproach.AlimentPharmacolTher.–2014Jul;40(1):119

30. IaniroG,BibbòS,GasbarriniA,CammarotaG.Therapeuticmodulationofgutmicrobiota:currentclinicalapplicationsandfutureperspectives.CurrDrugTargets.2014;15(8):762-70.

31. BibbòS,LopetusoLR,DiRienzoTA,IaniroG,GasbarriniA,CammarotaG.RoleofmicrobiotaandinnateimmunityinrecurrentClostridiumdifficileinfection.JImmunolRes2014;2014:462740.

32. ViggianoD, IaniroG, VanellaG,BibbòS,BrunoG, SimeoneG,MeleG.Gutbarrier inhealth anddisease:focusonchildhoodEurRevMedPharmacolSci

33. CammarotaG,IaniroG,BibbòS,GasbarriniA.Letter:telmisartanassociatedenteropathy-isthereanyclasseffect?Authors'reply.AlimentPharmacolTher.2014Sep;40(5):570.

34. Franceschi F, Tortora A, Di Rienzo T, D’angelo G, Ianiro G, Scaldaferri F, Gerardi V, Tesori V,LopetusoLR,GasbarriniARoleofHelicobacterpyloriinfectiononnutritionandmetabolism.WorldJGastroenterol.2014Sep28;20(36):12809-12817.

35. Ianiro G, Franceschi F, Bibbò S, Gasbarrini A. Omega-3 fatty acids: a novel resort againstgastrointestinalinjury.EurRevMedPharmacolSci.2014Oct;18(20):3086-90.

36. IaniroG, Bibbò S, Scaldaferri F, GasbarriniA, CammarotaG. Fecalmicrobiota transplantation ininflammatoryboweldisease:beyondtheexcitement.Medicine(Baltimore).2014Oct;93(19):e97.

37. CammarotaG,IaniroG,BibbòS,GasbarriniA.FecalMicrobiotaTransplantation:ANewOldKidontheBlock for theManagementofGutMicrobiota-relatedDisease. JClinGastroenterol.2014Nov-Dec;48Suppl1:S80-4.

38. OjettiV,IaniroG,TortoraA,D'AngeloG,DiRienzoTA,BibbòS,MignecoA,GasbarriniA.Theeffectof Lactobacillus reuteri supplementation in adults with chronic functional constipation: arandomized,double-blind,placebo-controlledtrial. JGastrointestinalLiverDis.2014Dec–[EpubAheadofPrint].

39. CammarotaG,IaniroG,CianciR,BibbòS,GasbarriniA,CurròD.Theinvolvementofgutmicrobiotaininflammatoryboweldiseasepathogenesis:potentialfortherapy.Pharmacology&Therapeutics.PharmacolTher.2015Jan3.pii:S0163-7258(14)00235-6.

40. LaterzaL,IaniroG,ScoleriI,LandiR,BrunoG,ScaldaferriF,GaetaniE,CampanaleM,GasbarriniA.Rifaximin for the treatment of diarrhoea-predominant irritable bowel syndrome. Expert OpinPharmacother.2015Mar;16(4):607-15.

41. CammarotaG,MasucciL, IaniroG,BibbòS,DinoiG,CostamagnaG,SanguinettiM,GasbarriniA.Randomizedclinicaltrial:faecalmicrobiotatransplantationbycolonoscopyversusvancomycinforthe treatment of recurrent Clostridium difficile infection. Aliment Pharmacol Ther 2015 – 2015May;41(9):835-43.

42. IaniroG,GasbarriniA.GastroenterologytraininginEurope:unmeteducationalneedsbeyondthemachines.Gut.2015Apr17.pii:gutjnl-2015-309535.

43. IaniroG,BibbòS,PecereS,GasbarriniA,CammarotaG.Current technologies for theendoscopicassessmentofduodenalvillouspatterninceliacdisease.ComputBiolMed.2015May1.pii:S0010-4825(15)00151-1.

44. Piscaglia AC, Rutella S, Laterza L, Cesario V, Campanale M, Cazzato IA, Ianiro G, Barbaro F, DiMaurizioL,BonannoG,CenciT,CammarotaG,LaroccaLM,GasbarriniA.Circulatinghematopoieticstemcellsandputativeintestinalstemcellsincoeliacdisease.JTranslMed.2015Jul11;13:220.

45. ScarpelliniE,IaniroG,AttiliF,BassanelliC,DeSantisA,GasbarriniA.Thehumangutmicrobiotaandvirome:potentialtherapeuticimplications.DigLiverDis.2015Jul18;[Epubaheadofprint]

46. Pecere S, SabatelliM, FantoniM, IaniroG, Gasbarrini A, Cammarota G. Letter: FecalmicrobiotatransplantationincombinationwithfidaxomicintotreatseverecomplicatedrecurrentClostridiumdifficileinfection-AlimentPharmacolTher2015Oct;42(8):1030.

47. IaniroG,Molina-InfanteJ,GasbarriniA.GastricMicrobiota.Helicobacter2015Sep;20Suppl1:68-71.

48. Cammarota G, Ianiro G, Magalini S, Gasbarrini A, Gui D. Decrease in Surgery for Clostridiumdifficile InfectionAfterStartingaProgramtoTransplantFecalMicrobiota.AnnInternMed.2015Sep15;163(6):487-8.

49. MangiolaF,IaniroG,FranceschiF,FagiuoliS,GasbarriniG,GasbarriniA.Roleofgutmicrobiotainautismandmooddisorders.WorldJGastroenterol–2016Jan7;22(1):361-8.

50. IaniroG, Bibbò S, Bruno G, Ricci R, Arena V, Gasbarrini A, Cammarota G. Priormisdiagnosis ofceliacdiseaseiscommonamongpatientsreferredtoatertiarycarecenter–aprospectivecohortstudy.ClinTranslGastroenterol2016Jan28;7:e139.

51. IaniroG,PecereS,GiorgioV,GasbarriniA,CammarotaG. DigestiveEnzymeSupplementation inGastrointestinalDiseases.CurrDrugMetabolism2016;17(2):187-93.

52. ScaldaferriF,PecereS,PetitoV,ZambranoD,FioreL,LopetusoLR,SchiavoniE,BrunoG,GerardiV,LaterzaL,PizzoferratoM,IaniroG,StojanovicJ,PosciaA,PapaA,ParoniSterbiniF,SanguinettiM,Masucci L, Cammarota G, Gasbarrini AEfficacy and mechanisms of action of fecal microbiotatransplantationinulcerativecolitis:pitfallsandpromisesfromafirstmetanalysis.TransplantProc–2016Mar;48(2):402-7.

53. Cammarota G., Pecere S., Ianiro G, Masucci L, Currò D. Principles of DNA-based gutmicrobiotaassessment and therapeutic efficacy of fecal microbiota transplantation in gastrointestinaldiseases.DigDis–2016;34(3):279-85.

54. IaniroG,GasbarriniA,CammarotaG.Olmesartan-associated sprue-like enteropathy: knowyourenemy.ScandJGastroenterol–2016Jul;51(7):891.

55. Lopetuso LR, IaniroG, Scaldaferri F, CammarotaG, Gasbarrini A. Gut Virome and InflammatoryBowelDisease.InflammBowelDis–2016Jul;22(7):1708-12

56. CammarotaG, IaniroG -Celiacdisease:how toevaluatebyendoscopyat thebest?. EndoscopyInternationalOpen–2016May;4(5):E547-8.

57. ScarpelliniE,LaterzaL,IaniroG,TackJ,AbenavoliL,GasbarriniA.Eluxadolineforthetreatmentofdiarrhoea-predominant irritable bowel syndrome. Expert Opin Pharmacother - 2016Jul;17(10):1395-402.

58. S. Bibbò, G. Ianiro, R. Ricci, D. Arciuolo, L. Petruzziello, C. Spada, A. Larghi, M.E. Riccioni, A.Gasbarrini,G.Costamagna,G.Cammarota -Barrett'sesophagusandassociateddysplasiaarenotequallydistributedwithintheesophagealcircumference.DigLiverDis-2016Sep;48(9):1043-7.

59. IaniroG,TilgH,GasbarriniA.Antibioticsasdeepmodulatorsofgutmicrobiota:betweengoodandevil.Gut–2016pii:gutjnl-2016-312297.

60. ParoniSterbiniF,PalladiniA,MasucciL,CannistraciCV,PastorinoR,IaniroG,BugliF,MartiniC,Ricciardi W, Gasbarrini A, Sanguinetti M, Cammarota G, Posteraro B. Effects of Proton Pump

Inhibitors on the Gastric Mucosa-Associated Microbiota in Dyspeptic Patients. Applied andEnvironmentalMicrobiology–2016Oct27;82(22):6633-6644.

61. GalloA,IaniroG,MontaltoM,CammarotaG.TheRoleofBiomarkersinDiverticularDisease.JClinGastroenterol.2016Oct;50Suppl1:S26-8.

62. CurròD,IaniroG,PecereS,BibbòS,CammarotaG.Probiotics,fibreandherbalmedicinalproductsfor functional and inflammatory bowel disorders. Br J Pharmacol. 2016 Oct 3. doi:10.1111/bph.13632.

63. BibbòS,IaniroG,GiorgioV,ScaldaferriF,MasucciL,GasbarriniA,CammarotaG.Theroleofdietongutmicrobiotacomposition.EurRevMedPharmacolSci.2016Nov;20(22):4742-4749.

64. IaniroG,ValerioL,MasucciL,PecereS,BibbòS,QuarantaG,PosteraroB,CurròD,SanguinettiM,GasbarriniA,CammarotaG.Predictorsof failureaftersingle faecalmicrobiota transplantation inpatientswith recurrentClostridiumdifficile infection: results froma3-year, single-centre cohortstudy.ClinMicrobiolInfect.2017Jan3.pii:S1198-743X(16)30657-7.

65. CammarotaG,IaniroG,TilgH,Rajilić-StojanovićM,KumpP,SatokariR,SokolH,ArkkilaP,PintusC,HartA,SegalJ,AloiM,MasucciL,MolinaroA,ScaldaferriF,GasbarriniG,Lopez-SanromanA,LinkA,deGrootP,deVosWM,HögenauerC,MalfertheinerP,MattilaE,MilosavljevićT,NieuwdorpM,Sanguinetti M, Simren M, Gasbarrini A; European FMT Working Group. European consensusconferenceon faecalmicrobiota transplantation inclinicalpractice.Gut.2017 Jan13.pii: gutjnl-2016-313017.

66. IaniroG,GasbarriniA,CammarotaG. IpilimumabAdjuvantTherapy inMelanoma.NEngl JMed.2017Jan26;376(4):398.

67. GibiinoG,FabbriC,FagiuoliS,IaniroG,FornelliA,CennamoV.Definingthebiologyofintrahepaticcholangiocarcinoma:molecular pathways and early detection of precursor lesions. EurRevMedPharmacolSci.2017Feb;21(4):730-741.

68. Ianiro G, Simren M. How to get your work published: Tricks and pearls. United EuropeanGastroenterolJ.2017Mar;5(2):300-301.

69. Ianiro G, Sanguinetti M, Gasbarrini A, Cammarota G. Predictors of failure after single faecalmicrobiotatransplantationinpatientswithrecurrentClostridiumdifficileinfection:resultsfromathree-year cohort study: authors' reply. Clin Microbiol Infect. 2017 2017 May 11. pii: S1198-743X(17)30260-4.

70. BibbòS,IaniroG,GasbarriniA,CammarotaG.Fecalmicrobiotatransplantation:past,presentandfutureperspectives.MinervaGastroenterolDietol.2017Dec;63(4):420-430.

71. GibiinoG,IaniroG,CammarotaG,GasbarriniA.Thegutmicrobiota: itsanatomyandphysiologyduringalllife.MinervaGastroenterolDietol.2017Dec;63(4):329-336.

72. Holleran G, Lopetuso LR, Ianiro G, Pecere S, PizzoferratoM, Petito V, Graziani C, McNamara D,GasbarriniA,ScaldaferriF.Gutmicrobiotaandinflammatoryboweldisease:sofarsogut!MinervaGastroenterolDietol.2017Dec;63(4):373-384.

73. IaniroG,CastroV,DolakW,IlieM,HolleranG,SalagaM,vanHerwaardenY,BurischJ;UEGYoungTalentGroup.TheorganisationandneedsofyoungsectionsbelongingtoUEGNationalSocieties:ResultsofaEurope-widesurvey.UnitedEuropeanGastroenterolJ.2017Aug;5(5):750-755.

74. HolleranG,LopetusoL,PetitoV,GrazianiC,IaniroG,McNamaraD,GasbarriniA,ScaldaferriF.TheInnate and Adaptive Immune System as Targets for Biologic Therapies in Inflammatory BowelDisease.IntJMolSci.2017Sep21;18(10).pii:E2020.

75. de Korwin JD, Ianiro G, Gibiino G, Gasbarrini A. Helicobacter pylori infection and extragastricdiseasesin2017.Helicobacter.2017Sep;22Suppl1.

76. CammarotaG, IaniroG, GasbarriniA. Faecalmicrobiota transplantation in clinical practice.Gut.2018Jan;67(1):196-197.

77. McIlroy J, Ianiro G, Mukhopadhya I, Hansen R, Hold GL. Review article: the gutmicrobiome ininflammatory bowel disease-avenues formicrobialmanagement. Aliment Pharmacol Ther. 2018Jan;47(1):26-42.

78. MaidaM,MacalusoFS,IaniroG,MangiolaF,SinagraE,HoldG,MaidaC,CammarotaG,GasbarriniA,ScarpullaG.Screeningofcolorectalcancer:presentandfuture.ExpertRevAnticancerTher.2017Dec;17(12):1131-1146.

79. CammarotaG,IaniroG.GutMicrobiotaandCancerPatients:ABroad-RangingRelationship.MayoClinProc.2017Nov;92(11):1605-1607.

80. IaniroG,CammarotaG,GasbarriniA.LetterbyIaniroetalRegardingArticle,"EffectofLong-TermMetforminandLifestyle intheDiabetesPreventionProgramandItsOutcomeStudyonCoronaryArteryCalcium".Circulation.2018Jan;137(2):213-214.

81. MaidaM,McilroyJ,IaniroG,CammarotaG.FaecalMicrobiotaTransplantationasEmergingTreatmentinEuropeanCountries.AdvExpMedBiol.2018;1050:177-195.

82. BibbòS,IaniroG,DoreMP,SimonelliC,NewtonEE,CammarotaG.GutMicrobiotaasaDriverofInflammationinNonalcoholicFattyLiverDisease.MediatorsInflamm.2018Jan;2018:9321643.

83. RizzattiG,MatteoMV,IaniroG,CammarotaG,FranceschiF,GasbarriniA.Helicobacterpyloriinmetabolicrelateddiseases.MinervaGastroenterolDietol.2018Sep;64(3):297-309

84. HolleranG,ScaldaferriF,IaniroG,LopetusoL,McNamaraD,MeleMC,GasbarriniA,CammarotaG.FecalmicrobiotatransplantationforthetreatmentofpatientswithulcerativecolitisandothergastrointestinalconditionsbeyondClostridiumdifficileinfection:anupdate.DrugsToday(Barc).2018Feb;54(2):123-136.

85. QuagliarielloA,DelChiericoF,RussoA,ReddelS,ConteG,LopetusoLR,IaniroG,DallapiccolaB,CardonaF,GasbarriniA,PutignaniL.GutMicrobiotaProfilingandGut-BrainCrosstalkinChildrenAffectedbyPediatricAcute-OnsetNeuropsychiatricSyndromeandPediatricAutoimmuneNeuropsychiatricDisordersAssociatedWithStreptococcalInfections.FrontMicrobiol.2018Apr6;9:675.

86. IaniroG,MasucciL,QuarantaG,SimonelliC,LopetusoLR,SanguinettiM,GasbarriniA,CammarotaG.Randomisedclinicaltrial:faecalmicrobiotatransplantationbycolonoscopyplusvancomycinforthetreatmentofsevererefractoryClostridiumdifficileinfection-singleversusmultipleinfusions.AlimentPharmacolTher.2018Jul;48(2):152-159.

87. RizzattiG,IaniroG,GasbarriniA.AntibioticandModulationofMicrobiota:ANewParadigm?JClinGastroenterol.2018Nov/Dec;52Suppl1,Proceedingsfromthe9thProbiotics,PrebioticsandNewFoods,NutraceuticalsandBotanicalsforNutrition&HumanandMicrobiotaHealthMeeting,heldinRome,ItalyfromSeptember10to12,2017:S74-S77.

88. NuceraE,AruannoA,IaniroG,CammarotaG,GasbarriniA,SchiavinoD.Wheatdesensitizationtreatmentinpatientswithglutensensitivity.PostepyDermatolAlergol.2018Jun;35(3):320-322.

89. IaniroG,RizzattiG,PlomerM,LopetusoL,ScaldaferriF,FranceschiF,CammarotaG,GasbarriniA.BacillusclausiifortheTreatmentofAcuteDiarrheainChildren:ASystematicReviewandMeta-AnalysisofRandomizedControlledTrials.Nutrients.2018Aug;10(8).pii:E1074.

90. IaniroG,MaidaM,BurischJ,SimonelliC,HoldG,VentimigliaM,GasbarriniA,CammarotaG.EfficacyofdifferentfaecalmicrobiotatransplantationprotocolsforClostridiumdifficileinfection:Asystematicreviewandmeta-analysis.UnitedEuropeanGastroenterolJ.2018Oct;6(8):1232-1244.

91. deBelvisAG,BarbaraA,GiubbiniG,TragliaS,AngiolettiC,IaniroG,MasucciL,SanguinettiM,LaurentiP,CambieriA,GasbarriniA,RicciardiW,CammarotaG.ImpactevaluationofaCriticalPathwayforpatientswithClostridiumdifficileinfection:Apre-postanalysisinaThirdLevelReferralCenter.IntJInfectDis.2019Mar;80:105-110.

92. MaidaM,MorrealeG,SinagraE,IaniroG,MargheritaV,CirroneCipollaA,CamilleriS.Qualitymeasuresimprovingendoscopicscreeningofcolorectalcancer:areviewoftheliterature.ExpertRevAnticancerTher.2019Mar;19(3):223-235.

93. CianciR,FranzaL,SchinzariG,RossiE,IaniroG,TortoraG,GasbarriniA,GambassiG,CammarotaG.TheInterplaybetweenImmunityandMicrobiotaatIntestinalImmunologicalNiche:TheCaseofCancer.IntJMolSci.2019Jan;20(3).pii:E501.

94. NakovR,VelikovaT,NakovV,IaniroG,GerovaV,TankovaL.Serumtrefoilfactor3predictsdiseaseactivityinpatientswithulcerativecolitis.EurRevMedPharmacolSci.2019Jan;23(2):788-794.

95. CammarotaG,GalloA,IaniroG,MontaltoM.Emergingdrugsforthetreatmentofclostridiumdifficile.ExpertOpinEmergDrugs.2019;24(1):17-28.

96. CammarotaG,IaniroG.FMTforulcerativecolitis:closertotheturningpoint.NatRevGastroenterolHepatol.2019May;16(5):266-268.

97. IaniroG,RizzattiG,NapoliM,MatteoMV,RinninellaE,MoraV,FanaliC,LeonettiA,BenedettelliS,MeleMC,CammarotaG,GasbarriniA.ADurumWheatVariety-BasedProductIsEffectiveinReducingSymptomsinPatientswithNon-CeliacGlutenSensitivity:ADouble-BlindRandomizedCross-OverTrial.Nutrients.2019Mar;11(4).pii:E712.

98. IaniroG,EusebiLH,BlackCJ,GasbarriniA,CammarotaG,FordAC.Systematicreviewwithmeta-

analysis:efficacyoffaecalmicrobiotatransplantationforthetreatmentofirritablebowelsyndrome.AlimentPharmacolTher.2019Aug;50(3):240-248.

99. IaniroG,PonzianiFR,GasbarriniA,CammarotaG.Letter:improvementofclinicaloutcomesbymetformininmetabolicliverdisease-amicrobiota-dependentmechanism?.AlimentPharmacolTher.2019May28.[Epubaheadofprint]

100. IaniroG,MurriR,SciumèGD,ImpagnatielloM,MasucciL,FordAC,LawG,TilgH,SanguinettiM,CaudaR,GasbarriniA,FantoniM,CammarotaG.Incidenceofbloodstreaminfections,lengthofhospitalstayandsurvivalinpatientswithrecurrentClostridioidesdifficileinfectiontreatedwithfecalmicrobiotatransplantationorantibiotics:aprospectivecohortstudy.AnnInternMed2019(inpress).

BOOKCHAPTERS1. “Secrezionegastricaincondizioninormaliepatologiche”–IaniroG,CazzatoA,CammarotaG,GasbarriniG-

Vol.VIII“Malattiedelcanaledigerente”,“TrattatodiMedicinaInternafondatodaPaoloLarizza”-EdizioniPiccin,2009

2. “Ematemesiemelena”-CazzatoA,IaniroG-“Trattatodimedicinainterna”diG.Gasbarrini-VerduciEditore2010

3. “Altritipidicoliti”–IaniroG,GasbarriniG,CammarotaG–“Trattatodimedicinainterna”diG.Gasbarrini-VerduciEditore,2010

4. “Ruolodelmicrobiotanellemalattiadell’apparatodigerente.Sindromedell’intestinoirritabile”–IaniroG,GiganteG,PizzoferratoM.–Ilmicrobiotaintestinale–diA.Gasbarrini–VerduciEditore,2013

5. “Ruolodelmicrobiotanellamalattiemetaboliche.Obesità”–GiganteG,IaniroG,OjettiV.–Ilmicrobiotaintestinale–diA.Gasbarrini–VerduciEditore,2013

ABSTRACTSAuthororco-authorofmorethan90abstractsacceptedaspostersorasoralcommunicationstomanynationalandinternationalgastroenterologyconferences(asDDWorUEGW).Rome,September2,2019

Signature